NLNK - NewLink Genetics Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Cash flows from operating activities
Net Income
-38,142
-53,595
-71,951
-85,155
-40,381
Depreciation & amortization
875
1,145
1,407
6,042
1,592
Deferred income taxes
-
-
-
-
-
Stock based compensation
11,840
17,120
18,508
16,707
15,940
Change in working capital
-6,384
-2,711
3,629
-3,144
-1,238
Accounts receivable
-
-
-
-
-
Inventory
-
-
-
-
-
Accounts Payable
-
-13,029
-
-
-
Other working capital
-31,670
-37,946
-48,324
-68,193
-28,082
Other non-cash items
-
-
-
16,707
15,940
Net cash provided by operating activites
-31,670
-37,939
-48,281
-65,947
-24,087
Cash flows from investing activities
Investments in property, plant and equipment
-
-7
-43
-2,246
-3,995
Acquisitions, net
-
-
-
-
-
Purchases of investments
-
-
-
0
-
Sales/Maturities of investments
-
0
-
2,180
10,213
Other investing activites
-
-
-
0
0
Net cash used for investing activites
25
117
211
-66
6,218
Cash flows from financing activities
Debt repayment
-92
-167
-246
-257
-194
Common stock issued
-206
0
74,416
2,222
17,740
Common stock repurchased
-45
-275
-289
-82
-561
Dividends Paid
-
-
-
-
-
Other financing activites
-
-
-
0
6,100
Net cash used privided by (used for) financing activities
-49
-148
75,288
1,883
23,085
Net change in cash
-31,694
-37,970
27,218
-64,130
5,216
Cash at beginning of period
137,066
158,708
131,490
195,620
190,404
Cash at end of period
105,372
120,738
158,708
131,490
195,620
Free Cash Flow
Operating Cash Flow
-31,670
-37,939
-48,281
-65,947
-24,087
Capital Expenditure
-
-7
-43
-2,246
-3,995
Free Cash Flow
-31,670
-37,946
-48,324
-68,193
-28,082